Finance dispute halts new malaria treatment project
Ambitious plans to save hundreds of thousands of lives a year with new anti-malaria treatments are being held up by a dispute about how their production will be financed. Novartis, the Swiss
Ambitious plans to save hundreds of thousands of lives a year with new anti-malaria treatments are being held up by a dispute about how their production will be financed. Novartis, the Swiss